Detalles de la búsqueda
1.
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.
Br J Cancer
; 130(3): 417-424, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38097741
2.
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group.
BMC Cancer
; 21(1): 230, 2021 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676426
3.
Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer.
Eur J Cancer Care (Engl)
; 28(6): e13164, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31571304
4.
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.
Transl Lung Cancer Res
; 11(1): 53-63, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35242627
5.
Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection.
Lung Cancer
; 153: 25-34, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33453470
6.
Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment.
Eur J Cancer
; 149: 61-72, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33831609
7.
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study.
BMC Psychol
; 8(1): 123, 2020 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33228796
Resultados
1 -
7
de 7
1
Próxima >
>>